Twitter stops policing Covid-19 misinformation under CEO Elon Musk and reportedly restores 62,000 suspended accounts

Twitter stops policing Covid-19 misinformation under CEO Elon Musk and reportedly restores 62,000 suspended accounts


Elon Musk’s Twitter account displayed on a mobile with Elon Musk in the background are seen in this illustration. In Brussels – Belgium on 19 November 2022. 

Jonathan Raa | Nurphoto | Getty Images

In a recent update to its website, Twitter said that effective Nov. 23, it is no longer enforcing its Covid-19 misleading information policy.

It means the company will no longer prioritize removing or tagging misleading health information related to Covid-19.

Twitter said in December 2020 that it would begin to label and remove misinformation about Covid-19 vaccines as thousands of accounts made false claims about the coronavirus and the adverse impacts of immunizations.

Twitter CEO Elon Musk has been a vocal critic of how health officials reacted to the coronavirus pandemic. He said during the company’s first-quarter 2020 earnings call that the stay-at-home orders were “forcibly imprisoning people in their homes against all their constitutional rights.” He also said on “The Joe Rogan Experience” podcast in 2020 that the mortality rate of Covid-19 was much lower than health officials estimated.

Musk has committed to free speech on Twitter, which might partially explain why the change was enacted. But online safety experts have contended his approach has led to an increase in hate speech, harassment and misinformation on the platform.

Multiple civil rights groups earlier this month urged advertisers to pause advertising on Twitter after the company laid off thousands of employees, a move the groups feared would impede the company’s ability to moderate hateful and other problematic content.

Musk has claimed that hate speech impressions have decreased since October, though it is not entirely clear how Twitter has been measuring these impressions.

The change comes as technology newsletter Platformer says employees are scrambling to restore more than 62,000 suspended accounts. That figure could include some of the more than 11,000 accounts that were suspended for violating the company’s Covid-19 misinformation rules.

On Nov. 23, Musk shared a poll asking users whether Twitter should grant “general amnesty” to suspended accounts, as long as they had not engaged in “egregious spam” or broken any laws. “Yes” received 72.4% of votes, and “No” received 27.6%.

“The people have spoken,” Musk said in a tweet the next day. “Amnesty begins next week. Vox Populi, Vox Dei.”‘

The poll was not scientific or immune to participation from bots.

Musk used the same Latin phrase, meaning “the voice of the people, the voice of God,” on Nov. 19 to announce that former President Donald Trump’s Twitter account would be reinstated. Under previous ownership, Twitter issued a lifetime ban on Trump’s account after his promotion of the Jan. 6 insurrection.

The billionaire, who is also CEO of Tesla and SpaceX, was forced to pause the initial launch of its $8 per month Twitter Blue service after users abused the system by purchasing blue checkmarks to impersonate brands and famous people. He banned some impersonators before he shut the service down, however, again raising questions about his definition of free speech.

Musk did not immediately respond to a request for comment.





Source

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
Health

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale

Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill market. Eli Lilly stock slipped about half a percent this morning, while Novo Nordisk shares surged more than 8% after becoming the first to secure FDA approval for a GLP-1 weight-loss pill. “[Novo] got approval ahead of […]

Read More
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
Health

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, Nov. 24, 2025. Tom Little | Reuters The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts […]

Read More
UnitedHealth Group commits to improvements after independent audit, patient backlash
Health

UnitedHealth Group commits to improvements after independent audit, patient backlash

UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans | Reuters UnitedHealth Group on Friday released the first results from a sprawling independent audit of its business practices and committed to a wide range of steps to track and implement improvements in three specific areas. The health-care […]

Read More